Open AccessEffect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes
Author(s) -
Carol Wysham,
Anuj Bhargava,
Louis Chaykin,
Raymond de la Rosa,
Yehuda Handelsman,
Lone Troelsen,
Kajsa Kvist,
Paul Norwood
Publication year - 2017
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2017.7117
Subject(s) - medicine , insulin glargine , hypoglycemia , insulin degludec , insulin , glycemic , type 2 diabetes , diabetes mellitus , morning , type 1 diabetes , crossover study , randomized controlled trial , evening , endocrinology , pediatrics , placebo , physics , alternative medicine , pathology , astronomy
Hypoglycemia, a serious risk for insulin-treated patients with type 2 diabetes, negatively affects glycemic control.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom